BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nocentini A, Bonardi A, Pratesi S, Gratteri P, Dani C, Supuran CT. Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin. J Enzyme Inhib Med Chem 2022;37:487-501. [PMID: 34986721 DOI: 10.1080/14756366.2021.2020773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lei L, Changfa W, Jiangang W, Zhiheng C, Ting Y, Xiaoling Z, Yuling D, Yaqin W. Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns. Sci Rep 2022;12:14786. [PMID: 36042236 DOI: 10.1038/s41598-022-18988-x] [Reference Citation Analysis]
2 Pareek S, Flegle AS, Boagni D, Kim JY, Yoo D, Trujillo-Ocampo A, Lee SE, Zhang M, Jon S, Im JS. Post Transplantation Bilirubin Nanoparticles Ameliorate Murine Graft Versus Host Disease via a Reduction of Systemic and Local Inflammation. Front Immunol 2022;13:893659. [PMID: 35720391 DOI: 10.3389/fimmu.2022.893659] [Reference Citation Analysis]
3 Brasil FB, de Almeida FJS, Luckachaki MD, Dall'Oglio EL, de Oliveira MR. A Pretreatment with Isoorientin Attenuates Redox Disruption, Mitochondrial Impairment, and Inflammation Caused by Chlorpyrifos in a Dopaminergic Cell Line: Involvement of the Nrf2/HO-1 Axis. Neurotox Res 2022. [PMID: 35583593 DOI: 10.1007/s12640-022-00517-3] [Reference Citation Analysis]